I would think / hope that the FDA feels a certain sense of urgency here. We are losing people at the same rate as world war 2. Leronlimab has proven (as far as I’m concerned at this point proof positive) that it is a do no harm drug. We are at a financial precipice in this country. If the interim results are not enough to get eua one would think there is a serious disconnect somewhere. As an investor I think there is no choice to stick it out and wait for the interim unless the release of mm can shed some more light on any of this ie fda disposition or efficacy.